Delivery Order SPE2DB20D3103-SPE2DB24FL7D4

Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $67K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award SPE2DB22D3301|SPE2DB25FX5SH, valued at $12,066.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a medical pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,402.54 firm fixed-price delivery order contract, which has a completion date of March 10, 2025, is for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, SPE2DB20D1051|SPE2DB25FD5ZX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,044.05 firm fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $17,342.53 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which runs through November 2026. This IDC enables efficient government procurement of a...
This federal contract award, valued at $1,391.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VEMLIDY 25 MG TABLET UU 30S, with an ultimate completion date of March 25, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. In addition to this specific Delivery Order, Amerisourcebergen holds a...
This federal contract award, with ID number SPE2DB20D1100|SPE2DB25FZ57X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,499.81, is a delivery order for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024 and is a firm fixed-price arrangement. This award is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,816.32 Firm Fixed Price Delivery Order is for the supply of VEMLIDY 25 MG TABLET UU 30S, with a period of performance through January 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY6H0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,880.12 firm fixed-price delivery order is for the procurement of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $12,531.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a medical product. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,826.56 firm fixed-price delivery order is for VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL7D4
    Delivery Order

This federal contract award, identified as SPE2DB20D3103|SPE2DB24FL7D4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $66,806.09, is a Firm Fixed Price Delivery Order for the supply of VEMLIDY 25 MG TABLET UU 30S, a medical product.

The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/12/25, 10:44 AM